Rubella Vaccine

Rubella Vaccine is a freeze dried preparation of a suitable live attenuated strain of rubella virus grown in human diploid cell cultures. Rubella Vaccine is indicated for active immunization against rubella virus (German measles) to prevent or control outbreaks of rubella in children's 12 month of age or older and adults.

Rubella Vaccine is primarily indicated in conditions like Rubella prevention.

Rubella Vaccine is contraindicated in conditions like Hypersensitivity to any component of product.

The symptomatic adverse reactions produced by Rubella Vaccine are more or less tolerable and if they become severe, they can be treated symptomatically, these include Fever, Skin rashes, Pharyngitis, Syncope, Pain at site, Headache, Stevens-Johnson syndrome, Myalgia, Malaise, Bronchospasm, Nerve deafness, Conjunctivitis, Otitis media.

Vaccine should be used with caution in patients with any illness, infections, blood disorders or if have any allergy. It should not be given during pregnancy or lactation.

Drug should not be given to Pregnant Mothers. If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

0.5 ml (0.5 (0.5)) 24 hourly IM,SC — For females only.

0.5 ml (0.5 (0.5)) As recommended. Intra Muscular — For Once 0.5 ml (0.5 (0.5)) As recommended. Subcutaneous — For Once

No neonatal dosage information is recorded for this medicine yet.

Rubella Vaccine is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementPentostatinConcurrent use may potentiate a risk of disseminated infection due to enhanced replication of vaccine virus or bacteria in the presence of diminished immune competence.MajorIn general, live virus or bacterial vaccines should not be used in patients receiving immunosuppressive therapy or cancer chemotherapy. Vaccination should be deferred until after such therapy is discontinued for at least 3 months in most cases.Rho (D) Immune Globulin Antibodies found in immune globulins may interfere with the immune response to live vaccines.ModerateVaricella vaccine should not be given for at least 5 months after, and other live vaccines should not be given for at least 3 months after administration of immune globulin.RituximabThe administration of live, attenuated virus or bacterial vaccines during immunosuppressant or intense antineoplastic therapy may be associated with a risk of disseminated infection due to enhanced replication of vaccine virus or bacteria in the presence of diminished immune competence.MajorThe administration of live, attenuated virus or bacterial vaccines during immunosuppressant or intense antineoplastic therapy may be associated with a risk of disseminated infection due to enhanced replication of vaccine virus or bacteria in the presence of diminished immune competence. These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Inj Store in refrigerator. Do not Freeze. Protect from Sunlight.